COVID-19康复患者行初次全关节置换术的并发症发生率较高
本研究利用大型全国数据库,比较全关节置换术前6个月内确诊COVID-19的患者与COVID-19阴性对照(按年龄5岁区间、Charlson合并症指数和性别1:3匹配)术后90天内并发症的发生率。共纳入7,780例患者,结果显示术前0至3个月内确诊COVID-19的患者再入院、肺炎、深静脉血栓、肾衰竭和急性呼吸窘迫综合征的发生率均显著高于对照;术前3至6个月内确诊者肺炎和深静脉血栓发生率仍显著高于对照。
要点
- 术前0至3个月内确诊COVID-19者术后90天再入院率为14.0%,高于对照的11.1%(P = .001)。
- 术前3至6个月内确诊COVID-19者肺炎发生率为2.0%、深静脉血栓为3.6%,均高于对照的0.7%和1.9%。
- 作者认为术前3个月内确诊COVID-19的患者全关节置换术后90天并发症风险增加。
核心结论
- 术前3个月内确诊COVID-19的患者行全关节置换术后90天并发症风险增加;即使手术在确诊后3至6个月进行,肺炎和深静脉血栓风险仍升高。
研究设计与样本
- 研究使用大型全国数据库,纳入全髋关节置换术或全膝关节置换术前6个月内确诊COVID-19的患者,与COVID-19阴性对照按年龄5岁区间、Charlson合并症指数和性别1:3匹配,比较术后90天内并发症发生率。
- 共纳入7,780例患者:5,840例(75.1%)从未确诊COVID-19,1,390例(17.9%)术前0至3个月确诊,550例(7.1%)术前3至6个月确诊。
主要发现
- 与COVID-19阴性对照相比,术前0至3个月确诊COVID-19的患者再入院率为14.0%对11.1%(P = .001),肺炎为2.2%对0.7%(P < .001),深静脉血栓为3.3%对1.9%(P = .001),肾衰竭为2.4%对1.4%(P = .006),急性呼吸窘迫综合征为1.4%对0.7%(P = .01)。
- 与COVID-19阴性对照相比,术前3至6个月确诊COVID-19的患者肺炎发生率为2.0%对0.7%(P = .002),深静脉血栓为3.6%对1.9%(P = .005)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is limited data reviewing complication risks associated with total joint arthroplasty (TJA) after recovering from COVID-19. This study evaluated complications within 90 days of TJA in patients who had a COVID-19 diagnosis at varying intervals prior to surgery versus a non-COVID-19 cohort. METHODS: A large national database was used to identify patients diagnosed with COVID-19 in the six months prior to total hip arthroplasty (THA) or total knee arthroplasty. The incidence of complications within 90 days of surgery was recorded and compared to a COVID-19 negative control group matched 1:3 for age range in 5-year intervals, Charlson Comorbidity Index, and sex. There were 7,780 patients included in the study; 5,840 (75.1%) never diagnosed with COVID-19, 1,390 (17.9%) who had a COVID-19 diagnosis 0 to 3 months prior to surgery, and 550 (7.1%) who had a COVID-19 diagnosis 3 to 6 months prior to surgery. RESULTS: When compared to their COVID negative controls, patients who had a COVID-19 diagnosis 0 to 3 months prior to surgery had significantly higher rates of readmission (14.0 versus 11.1%, P = .001), pneumonia (2.2 versus 0.7%, P < .001), deep vein thrombosis (DVT) (3.3 versus 1.9%, P = .001), kidney failure (2.4 versus 1.4%, P = .006), and acute respiratory distress syndrome (1.4 versus 0.7%, P = .01). Patients who had a COVID-19 diagnosis 3 to 6 months prior to surgery had significantly higher rates of pneumonia (2.0 versus 0.7%, P = .002) and DVT (3.6 versus 1.9%, P = .005) when compared to their COVID negative controls. CONCLUSION: Patients diagnosed with COVID-19 within three months prior to TJA have an increased risk of 90-day postoperative complications. Risk for pneumonia and DVT remains elevated even when surgery was performed as far as 3 to 6 months after COVID-19 diagnosis.
引用
- Lee A, Durst CR, Rezzadeh KT, et al. Higher Complication Rate in COVID-19 Recovered Patients Undergoing Primary Total Joint Arthroplasty. J Arthroplasty. 2023. PMID: 37105327. doi:10.1016/j.arth.2023.04.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。